Evidence map›Paper›PMID 41756378›Full record

ArticleFrontiers in medicine2026

Enhanced preoperative prediction for microvascular invasion in hepatocellular carcinoma through an optimized MR Radiomics combination strategy and machine learning predictor.

Mengting Feng, Yingjian Yang, Zongbo Dai, Ziran Chen, Longyu Li, Zewei Wu, Xuejian Li, Tingwei Guo, Yiman Meng, Qiang Li and 4 more

Abstract read
In one paragraph

Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Mengting FengCollege of Medicine and Biological Information Engineering, Northeastern University, Shenyang, China.
Yingjian YangDepartment of Radiological Research and Development, Shenzhen Lanmage Medical Technology Co., Ltd., Shenzhen, Guangdong, China.
Zongbo DaiDepartment of Hepatobiliary Surgery, The First Hospital of China Medical University, Shenyang, China.
Ziran ChenCollege of Medicine and Biological Information Engineering, Northeastern University, Shenyang, China.
Longyu LiCollege of Medicine and Biological Information Engineering, Northeastern University, Shenyang, China.
Zewei WuCollege of Medicine and Biological Information Engineering, Northeastern University, Shenyang, China.
Xuejian LiDepartment of Hepatobiliary Surgery, The First Hospital of China Medical University, Shenyang, China.
Tingwei GuoDepartment of Hepatobiliary Surgery, The First Hospital of China Medical University, Shenyang, China.
Yiman MengDepartment of Hepatobiliary Surgery, The First Hospital of China Medical University, Shenyang, China.
Qiang LiSchool of Data and Computer Science, Shandong Women's University, Jinan, Shandong, China.
Zihao ZhaoCollege of Medicine and Biological Information Engineering, Northeastern University, Shenyang, China.
Tao LiCollege of Medicine and Biological Information Engineering, Northeastern University, Shenyang, China.
Jialin ZhangDepartment of Hepatobiliary Surgery, The First Hospital of China Medical University, Shenyang, China.
Yan KangCollege of Medicine and Biological Information Engineering, Northeastern University, Shenyang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Preoperative prediction of microvascular invasion (MVI) in hepatocellular carcinoma (HCC) is a crucial step toward personalized treatment, improved treatment outcomes, and enhanced patient survival. However, the disadvantage of existing prediction models of MVI in HCC based on enhanced magnetic resonance imaging (MRI) is that they require combining non-imaging information from enhanced MRI, or determining the perioperative region is highly subjective. These disadvantages are not conducive to the clinical application of predictive models, which hinders clinical decision-making and management for these vulnerable populations. Methods: To address the problem of combining non-imaging information from enhanced MRI with the highly subjective determination of the perioperative region, we propose an enhanced preoperative prediction model for MVI in HCC using an optimized MR Radiomics combination strategy and a machine learning predictor. First, the HCC was manually segmented from 125 × 512 × 512 × Results: The proposed MVI preoperative prediction model (RF + LASSO + SPECTRAL-10) achieves a mean accuracy of 0.7520 ± 0.0867, a mean precision of 0.7354 ± 0.1863, a mean recall of 0.6955 ± 0.2203, a mean Discussion: The proposed best preoperative prediction model can effectively predict MVI in HCC, potentially serving as a strong decision-making tool for these vulnerable populations.

Indexed as

enhanced T1-weighted magnetic resonance imaginghepatocellular carcinomamachine learning algorithmsmicrovascular invasionpreoperative predictionradiomics

Identifiers

PMID41756378
PMCPMC12932187

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.